Skip to main content
SpringerLink
Log in
Book cover

Pancreatic Cancer pp 255–267Cite as

European Adjuvant Trials

  • Chapter

  • 233 Accesses

Part of the book series: M. D. Anderson Solid Tumor Oncology Series ((MDA))

Conclusion

The results of large European randomized studies have been invaluable in determining a safe and standardized treatment protocol for patients with pancreatic cancer. It is clear that standard doses of postoperative adjuvant chemoradiotherapy have no survival advantage and may even be disadvantageous. Adjuvant chemotherapy, on the other hand, looks to be much more promising and warrants detailed evaluation. Further effective therapies can now be assessed within large cooperative organizations to improve the outlook, survival, expectancy, and quality of life for these patients. In this respect, ESPAC has been a major advance in clinical scientific investigation.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Parkin DM, Muir CS, Whelan SL, Sao Y-T, Ferlay J, Powell J, eds. Cancer Incidence in Five Continents. Vol 6. Lyon: International Agency for Research on Cancer; 1992. IARC Scientific Publications, No. 120.

    Google Scholar 

  2. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Incidence treatment and survival in 13,560 patients with pancreatic cancer: an epidemiological study in the West Midlands. Br J Surg. 1995;82:111–115.

    CAS  PubMed  Google Scholar 

  3. Neoptolemos JP, Russell RCG, Bramhall SR, Theis B. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. Br J Surg. 1997;84:1370–1376.

    Article  CAS  PubMed  Google Scholar 

  4. Lieberman MD, Kilburn H, Lindsey M, Brennan MF. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg. 1995;222:638–645.

    CAS  PubMed  Google Scholar 

  5. Wade TP, Halaby IA, Stapleton DR, Virgo KS, Johnson FE. Population-based analysis of treatment of pancreatic cancer and Whipple resection: Department of Defense hospitals 1989–1994. Surgery. 1996;120:680–687.

    CAS  PubMed  Google Scholar 

  6. Trede M, Schwall G, Saeger H-D. Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg. 1990;211:447–458.

    CAS  PubMed  Google Scholar 

  7. Cameron JL, Pitt HA, Yeo CJ, Lillimoe KD, Kaufman HS, Coleman J. One hundred forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg. 1993;217:430–438.

    CAS  PubMed  Google Scholar 

  8. Yeo CJ, Cameron JL, Lillimoe KD, et al. Pancreatoduodenectomy for cancer of the head of the pancreas in 201 patients. Ann Surg. 1995;221:721–733.

    CAS  PubMed  Google Scholar 

  9. Ishikawa O, Ohigashi H, Sasaki Y, et al. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg. 1998;208:215–220.

    Google Scholar 

  10. Nitecki SS, Sarr MG, Colby TV, Van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. It is really improving? Ann Surg. 1995;221:59–66.

    CAS  PubMed  Google Scholar 

  11. Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg. 1996;5:506–511.

    Google Scholar 

  12. Nagakawa T, Nagamori M, Futakami F, et al. Results of extensive surgery for pancreatic carcinoma. Cancer. 1996;77:640–645.

    Article  CAS  PubMed  Google Scholar 

  13. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg. 1996;83:625–631.

    CAS  PubMed  Google Scholar 

  14. Ohigashi H, Ishikawa O, Tamura S, et al. Pancreatic invasion as the prognostic indicator of duodenal adenocarcinoma created by pancreatoduodenectomy plus extended lymphadenectomy. Surgery. 1998;124:510–515.

    CAS  PubMed  Google Scholar 

  15. Pedrazzoli S, Dicarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg. 1998;228:508–517.

    Article  CAS  PubMed  Google Scholar 

  16. Neoptolemos JP, Bramhall SR, Kerr DJ. Adjuvant treatment in pancreatic cancer: combined modalities. In: Beger HG, Warshaw AL, Büchler MW, et al., eds. The Pancreas. Oxford, UK: Blackwell Science; 1998:1104–1119.

    Google Scholar 

  17. Satake K, Nishiwaki H, Yokomatsu H, et al. Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet. 1992;175:259–265.

    CAS  PubMed  Google Scholar 

  18. Whittington R, Bryer MP, Haller DG, Solin LJ, Rosato EF. Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 1991;21:1137–1143.

    CAS  PubMed  Google Scholar 

  19. Westerdahl J, Andren-Sandberg Å, Ihse I. Recurrence of exocrine pancreatic cancer—local or hepatic? Hepatogastroenterology. 1993;40:384–387.

    CAS  PubMed  Google Scholar 

  20. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer. 1993;72:2118–2123.

    CAS  PubMed  Google Scholar 

  21. Zerbi A, Fossati V, Parolini D, et al. Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer. 1994;73:2930–2935.

    CAS  PubMed  Google Scholar 

  22. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg. 1997;21:195–200.

    Article  CAS  PubMed  Google Scholar 

  23. Griffin JF, Smalley SR, Jewell W, et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer. 1990;66:56–61.

    CAS  PubMed  Google Scholar 

  24. Amikura K, Kobari M, Matsuno S. The time of occurrence of liver metastasis in carcinoma of the pancreas. Int J Pancreatol. 1995;17:139.

    CAS  PubMed  Google Scholar 

  25. McCarthy MJ, Evans J, Sagar G, Neoptolemos JP. Prediction of resectability of pancreatic malignancy by computed tomography. Br J Surg. 1998;85:320–325.

    CAS  PubMed  Google Scholar 

  26. Fernández-Del Castillo C. Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer. Br J Surg. 1995;82:1127–1129.

    PubMed  Google Scholar 

  27. Jones L, Russell C, Mosca F, et al. Standard Kausch-Whipple pancreatoduodenectomy. Dig Surg. 1999;16:297–304.

    Article  CAS  PubMed  Google Scholar 

  28. Pedrazzoli S, Beger HG, Obertop H, et al. A surgical and pathological-based classification of resective treatment of pancreatic cancer. Dig Surg. 1999;16:337–345.

    CAS  PubMed  Google Scholar 

  29. Di Carlo V, Zerbi A, Balzano G, Corso V. Pyloruspreserving pancreaticoduodenectomy versus conventional Whipple operation. World J Surg. 1999;23:920–925.

    Article  PubMed  Google Scholar 

  30. Edge SB, Schmieg R Jr, Rosenlof LK, Willheim MC. Pancreas cancer resection outcome in American university centers in 1989–1990. Cancer. 1993;71:3502–3508.

    CAS  PubMed  Google Scholar 

  31. Wade TP, Kraybill WG, Virgo KS, Johnson FE. Pancreatic cancer treatment in the United States veteran from 1987–1991—effect of tumour stage on survival. J Surg Oncol. 1995;58:104–111.

    CAS  PubMed  Google Scholar 

  32. Millikan KW, Deziel DJ, Silverstein JC, et al. Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg. 1999;65:618–623.

    CAS  PubMed  Google Scholar 

  33. Allema JH, Reinders ME, Vangulik TM, et al. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer. 1995;75:2069–2076.

    CAS  PubMed  Google Scholar 

  34. Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg. 1993;217:144–148.

    CAS  PubMed  Google Scholar 

  35. Gunderson LL, Nagorney DM, Martenson JA, Donahue JH, Gorton GR, Nelson H. External beam plus intra-operative irradiation for gastrointestinal cancers. World J Surg. 1995;19:191–197.

    Article  CAS  PubMed  Google Scholar 

  36. Tisdale BA, Paris KJ, Lindberg RD, Jose B, Spanos WJ. Radiation therapy for pancreatic cancer—a retrospective study of the University of Louisville experience. South Med J. 1995;88:741–744.

    CAS  PubMed  Google Scholar 

  37. Haycox A, Lombard M, Neoptolemos JP, Walley T. Review article: current treatment and optimal patient management in pancreatic cancer. Aliment Pharmacol Ther. 1998;12:949–964.

    CAS  PubMed  Google Scholar 

  38. Shibamoto Y, Manabe T, Baba M. High-dose external beam and intraoperative radiotherapy in the treatment of resectable and unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 1990;19:605–611.

    CAS  PubMed  Google Scholar 

  39. Shibamoto Y, Manabe T, Gakuji O, et al. High-dose intraoperative radiotherapy for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 1996;34:57–63.

    Article  CAS  PubMed  Google Scholar 

  40. Gunderson LL, Martin JK, Kvols LT. Intraoperative and external beam irradiation ±5FU for locally advanced pancreatic cancer. Int J Radiat Oncol Biol. 1987;13:319–325.

    CAS  Google Scholar 

  41. Garton GR, Gunderson LL, Nagorney DM, et al. High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 1993;27:1153–1157.

    CAS  PubMed  Google Scholar 

  42. Komaki R, Wadler S, Peters T, et al. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801). Cancer. 1992;69:2807–2812.

    CAS  PubMed  Google Scholar 

  43. Evans DB, Abbruzzese JL, Cleary KR, et al. Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation. Int J Radiat Oncol Biol Phys. 1995;33:913–918.

    Article  CAS  PubMed  Google Scholar 

  44. Gastrointestinal Tumour Study Group. Therapy of locally unresectable pancreatic carcinoma: a randomised comparison of high-dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high-dose radiation + 5-fluorouracil. Cancer. 1981;48:1705–1710.

    Google Scholar 

  45. Prott FJ, Schonekaes K, Preusser P, et al. Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study. Br J Cancer. 1997;75:597–601.

    CAS  PubMed  Google Scholar 

  46. Splinter TA, Obertop H, Kok TC, Jeekel J. Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomised pilot study. J Cancer Res Clin Oncol. 1989;115:200–202.

    CAS  PubMed  Google Scholar 

  47. Bakkevold KE, Arnesjo B, Dahl O, Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater—results of a controlled, prospective, randomised multicentre study. Eur J Cancer. 1993;5:698–703.

    Google Scholar 

  48. Baumel H, Huguier M, Manderscheid JC, Fabre JM, Houry S, Fagot H. Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg. 1994;81:102–107.

    CAS  PubMed  Google Scholar 

  49. Johnstone PA, Sindelar WF. Patients of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy correlations of a clinical trial. Int J Radiat Oncol Biol Phys. 1993;27:831–834.

    CAS  PubMed  Google Scholar 

  50. Dobelbower RR, Merrick HW, Khuder S, Battle J, Herron L, Pawlicki T. Adjuvant radiation therapy for pancreatic cancer: a 15-year experience. Int J Radiat Oncol Biol Phys. 1997;39:31–37.

    Article  CAS  PubMed  Google Scholar 

  51. Farrell TJ, Barbot D, Rosato F. Pancreatic resection combined with intraoperative radiation therapy for pancreatic cancer. Ann Surg. 1997;226:66–69.

    Article  CAS  PubMed  Google Scholar 

  52. Hishinuma S, Ogata Y, Matsui J, Ozawa I. Results of surgery and adjuvant radiotherapy for pancreatic cancer. J Hepatobiliary Pancreat Surg. 1998;5:143–150.

    Article  CAS  PubMed  Google Scholar 

  53. Hiraoka T. Extended radical resection of cancer of the pancreas with intraoperative radiotherapy. Ballière’s Clin Gastroenterol. 1990;4:985–99

    CAS  Google Scholar 

  54. Ozaki H, Kinoshita T, Kosuge T, Egawa S, Kishi K. Effectiveness of multimodality treatment for resectable pancreatic cancer. Int J Pancreatol. 1990;7:195–200.

    CAS  PubMed  Google Scholar 

  55. Nishimura Y, Hosotani R, Shibamoto Y, et al. External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complication. Int J Radiat Oncol Biol Phys. 1997;39:39–49.

    CAS  PubMed  Google Scholar 

  56. Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg. 1999;230:776–784.

    Article  CAS  PubMed  Google Scholar 

  57. Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 1985;120:899–903.

    CAS  PubMed  Google Scholar 

  58. Douglass HO. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer. 1987;59:2006–2010.

    Google Scholar 

  59. Beger HG, Gansauge F, Buchler MW, Link KH. Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis. World J Surg. 1999;23:946–940.

    Article  CAS  PubMed  Google Scholar 

  60. Ishikawa O, Ohigashi H, Sasaki Y, et al. Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg. 1994;168:361–364.

    Article  CAS  PubMed  Google Scholar 

  61. Ozaki H. Modern surgical treatment of pancreatic cancer. Int J Pancreatol. 1994;16:121–129.

    CAS  PubMed  Google Scholar 

  62. Link KH, Gansauge F, Pillasch J, Rilinger N, Büchler M, Beger HG. Regional treatment of advanced nonresectable and of resected pancreatic cancer via celiac axis infusion. First results of a single institution study. Dig Surg. 1994;11:414–419.

    Google Scholar 

  63. Ishikawa O, Ohigashi H, Imaoka S, et al. Is the longterm survival rate improved by preoperative irradiation prior to Whipple’s procedure for adenocarcinoma of the pancreatic head? Arch Surg. 1994;129:1075–1080.

    CAS  PubMed  Google Scholar 

  64. Hoffman JP, Lipsitz S, Pisansky T, Weese JL, Solin L, Benson AB III. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group study. J Clin Oncol. 1998;16:317–323.

    CAS  PubMed  Google Scholar 

  65. Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. 1992;127:1335–1339.

    CAS  PubMed  Google Scholar 

  66. Coia L, Hoffman J, Schier R, et al. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys. 1994;30:161–167.

    CAS  PubMed  Google Scholar 

  67. Staley CA, Lee JE, Clearly KR, et al. Preoperative chemoradiation pancreaticoduodenectomy and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg. 1996;171:118–124.

    Article  CAS  PubMed  Google Scholar 

  68. Spitz FR, Abbruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol. 1997;15:928–937.

    CAS  PubMed  Google Scholar 

  69. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg. 1996;223:273–279.

    CAS  PubMed  Google Scholar 

  70. Yeo C, Abrams R, Grochow L, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival: a prospective, single institution experience. Ann Surg. 1997;225:621–633.

    Article  CAS  PubMed  Google Scholar 

  71. Neoptolemos JP. Adjuvant radiotherapy and followon chemotherapy in patients with pancreatic cancer: results of the UK Pancreatic Cancer Study Group (UKPACA-1). GI Cancer. 1998;2:235–245.

    Google Scholar 

  72. Abrams RA, Grochow LB, Chakravarthy A, et al. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Radiat Oncol Biol Phys. 1999;44:1039–1046.

    Article  CAS  PubMed  Google Scholar 

  73. Neoptolemos JP, Baker P, Beger H, et al. Progress report: a randomised multicentre European study comparing adjuvant radiotherapy, six-months chemotherapy and combination therapy versus no adjuvant treatment in resectable pancreatic cancer. Int J Pancreatol. 1997;21:97–104.

    CAS  PubMed  Google Scholar 

  74. Neoptolemos JP, Dunn JA, Moffitt DD, et al. ESPAC-1 interim results: a European randomised study to assess the roles of adjuvant chemotherapy (5FU + folinic acid) and adjuvant chemoradiation (40 Gy + 5FU) in resectable pancreatic cancer. In: ASCO Proceedings. 2000;19:238.

    Google Scholar 

Download references

Authors
  1. Paula Ghaneh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jennifer Almond
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Deborah Moffitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Janet Dunn
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John Slavin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Robert Sutton
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Claudio Bassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Paolo Pederzoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hans G. Beger
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Karl H. Link
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Helmut Freiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Markus Büchler
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. John P. Neoptolemos
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA

    Douglas B. Evans M.D. (Professor of Surgery) & Peter W. T. Pisters M.D., F.A.C.S. (Associate Professor of Surgery) (Professor of Surgery) &  (Associate Professor of Surgery)

  2. Department of Gastrointestinal Medical Oncology, The University Texas M.D. Anderson Cancer Center, Houston, TX, 77030, USA

    James L. Abbruzzese M.D. (Professor of Medical Oncology, Chairman) (Professor of Medical Oncology, Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Ghaneh, P. et al. (2002). European Adjuvant Trials. In: Evans, D.B., Pisters, P.W.T., Abbruzzese, J.L. (eds) Pancreatic Cancer. M. D. Anderson Solid Tumor Oncology Series. Springer, New York, NY. https://doi.org/10.1007/0-387-21600-6_22

Download citation

  • DOI: https://doi.org/10.1007/0-387-21600-6_22

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95185-0

  • Online ISBN: 978-0-387-21600-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation